IPO Issue Details
Issue Price / Price Band₹300 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size50 Shares per Lot
Total Issue Size2,28,85,023 shares (aggregating up to ₹686.55 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenWed, 26 Jul 2023
Subscription CloseFri, 28 Jul 2023
Anchor AllotmentTue, 25 Jul 2023
Basis of AllotmentWed, 02 Aug 2023
Initiation of RefundsThu, 03 Aug 2023
Credit of Shares to DematFri, 04 Aug 2023
Listing DateMon, 07 Aug 2023
UPI Mandate Deadline2023-07-28
Application & Investment Details
Retail — Min (1 Lots)₹15,000 — 50 shares
Retail — Max (13 Lots)₹195,000 (13 Lots)
HNI — Min (14 Lots)₹2,10,000 — 700 shares
EPS (Pre-IPO)₹10.09
P/E Ratio (Pre-IPO)39.16x
Post-IPO Promoter Holding8,58,50,233 shares
Fresh Issue Shares1,63,33,333 shares (aggregating up to ₹490.00 Cr)
Offer for Sale Shares65,51,690 shares of ₹10 (aggregating up to ₹196.55 Cr)
About Yatharth Hospital & Trauma Care Services Ltd.
Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospital chain. Yatharth Hospital operates through its super specialty hospitals. These hospitals are situated in Delhi NCR, i.e., at Noida, Greater Noida, and Noida Extension, Uttar Pradesh. The hospital located in Noida Extension Hospital has 450 beds and is one of the largest hospitals in the area.Yatharth Hospital and Trauma Care Services provide patients with various Amenities and facilities. All of their hospitals are accredited by the NABH. And the ones located at Greater Noida and Noida Extension are accredited by NABL. The hospitals comply with all necessary international quality standards to ensure safety and recovery of the patients.The company acquired a 305-bedded multi-specialty hospital in Orchha, Madhya Pradesh to extend its operations and services.A team of 370 doctors is engaged with the company. They offer healthcare services across numerous specialties and super specialties.The super specialty or Centres of Excellence (COE) of the hospital includes:Centre of Medicine, Centre of General Surgery, Centre of Gastroenterology, Centre of Cardiology, Centre of Nephrology & Urology, Centre of Pulmonology, Centre of Neurosciences, Centre of Paediatrics, Centre of Gynaecology, Centre of Orthopaedics and Spine & Rheumatology.
Objects of the Issue
Yatharth Hospital & Trauma Care Services Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 Repayment/ prepayment, in full or part, of certain borrowings availed by the Company.
100.00
2
2 Repayment/ prepayment, in full or part, of certain borrowings availed by our Subsidiaries, namely, AKS Medical & Research Centre Private Limited (“AKS”) and Ramraja Multispeciality Hospital & Trauma Centre Private Limited (“Ramraja”)
145.00
3
3 Funding capital expenditure expenses of our Company for two hospitals, namely, Noida Hospital and Greater Noida Hospital.
25.64
4
4 Funding capital expenditure expenses of our Subsidiaries, AKS and Ramraja, for respective hospital operated by them.
106.97
5
5 Funding inorganic growth initiatives through acquisitions and other strategic initiatives
65.00
6
6 General corporate purposes.
127.10
Shareholding & Lock-in
Pre-IPO Promoter Holding
Not Available
Post-IPO Promoter Holding
8,58,50,233 shares
Lock-in Period (30%)September 1, 2023
Lock-in Period (50%)October 31, 2023